Abstract. Capsaicin and resveratrol are strong chemopreventive agents with promising human consumption safety records and anticarcinogenic activities. However, the mechanism by which they induce apoptosis in tumor cells remains to be defined. In this study, we examined the role of nitric oxide (NO • ) during apoptosis induced by these agents in A375 human melanoma cells. Capsaicin and resveratrol, alone or in combination, inhibited cell growth and promoted apoptosis by the elevation of NO
Introduction
Melanoma, a solid tumor that arises from pigment-producing melanocytes, is the most aggressive and lethal type of cutaneous cancer and is notoriously resistant to all current modalities of cancer therapy (1, 2) . Melanoma represents only 4% of all skin cancers, but almost 80% of skin cancer mortality (1, 3, 4) . Alternative options for patients with malignancies include natural compound treatments that have been used for a number of years throughout the world (5) (6) (7) (8) (9) . Among natural compounds, capsaicin (N-vanilly-8-methyl-1-nonenamide) and resveratrol (trans-3,5,4'-trihydroxystilbene) have experienced increasing attention from the scientific and medical field due to their substantial antimutagenic and anticarcinogenic potentials (6, (10) (11) (12) . However, the molecular mechanism by which they selectively induce apoptosis in cancer cells has not yet been fully elucidated.
Nitric oxide (NO • ), a product synthesized endogenously via arginine metabolism by various isoforms of nitric oxide synthase (NOS), is a pleiotropic signaling molecule that facilitates a wide variety of basic cellular functions and manifests itself pathophysiologically (13) . The effects of capsaicin-induced NO
• production have been reported in rat pheochromocytoma, PC-12 (14) and C6 glioma (15) cells. Some in vitro studies have shown that resveratrol is capable of inducing apoptosis through the elevation of NO
• concentration in the human breast cancer cell line MCF-7 (16) and exerts antiproliferative action on HepG2 hepatocellular carcinoma cells by NOS activation (17) .
Based on the collective evidence that capsaicin and resveratrol share the ability to stimulate NO
• production in certain cell types, we hypothesized that they may act synergistically in the induction of apoptosis via this pathway. To test this hypothe sis, we examined mechanisms of death signaling induced by capsaicin and resveratrol with special emphasis on the role of NO • , employing A375 human melanoma cells. We selected this cell line as existing evidence suggests the possible involvement of NO
• in the etiology of melanoma (18) .
Materials and methods
Cell cultures and chemicals. The melanoma cell line, A375, kindly provided by Dr G.N. Wogan (Massachusetts Institute of Technology, USA) was cultured in high glucose Dulbecco's modified Eagle's medium (DMEM) containing 10% heat-inactivated fetal bovine serum, 100 units/ml penicillin, 100 µg/ml streptomycin and 2 mM L-glutamine under 5% CO 2 at 37˚C. All cell culture reagents were purchased from Lonza (Walkersville, MD, USA). Capsaicin, resveratrol, Ac-DEVD-CHO and a GenElute™ mammalian genomic DNA miniprep kit were purchased from Sigma (St. Louis, MO, USA), and N-methyl-L-arginine monoacetate (NMA) was from CalBiochem (Salt Lake City, UT, USA). A total NO quantitative detection kit was purchased from R&D Systems (Minneapolis, MN, USA); the Annexin V-FITC apoptotic assay kit was from Clontech Laboratories (Palo Alto, CA, USA); Mitochndria/Cytosol Fractionation kit was purchased from Biovision (Mountain View, CA, USA); the ECL™ Western blotting detection reagents was from GE Healthcare Bio-Sciences (Piscataway, NJ, USA); and the ApoAlert Caspase-3 Colorimetric Assay kit was from Clontech (Mountain View, CA, USA). RIPA lysis buffer, anti-NOS1 (neuronal NOS, nNOS), anti-NOS2 (iNOS), anti-NOS-3 (endothelial NOS, eNOS), and anti-bcl-2 antibodies, as well as secondary goat anti-rabbit or anti-mouse IgG conjugated to horseradish peroxidase were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA); anti-Bax, anti-caspase 8 and 3 antibodies were from Cell Signaling Technology (Beverly, MA, USA); anti-DR4 and anti-Fas antibodies were from StressGen Biotechnologies Corp (Victoria, BC, Canada); anti-caspase 9, anti-Mdm2 and anti-cytochrome c antibodies were from BD Pharmingen (San Diego, CA, USA); and anti-p53 and anti-actin antibodies were provided by Oncogene (Cambridge, MA, USA).
Growth and cell viability analysis. A375 cells were placed in 24-well plates at a density of 1x10 5 cells/well. Different concentrations of capsaicin or resveratrol were then added to the cells for final concentrations of 10, 25, 50, 100 and 200 µM for 24 h, or 100 µM capsaicin and/or 50 µM resveratrol for different periods of time, and dimethyl sulfoxide (DMSO; solvent) only for the control regimen, and grown at 37˚C, in 5% CO 2 . Adherent and non-adherent cells were pooled after the 24-h treatment and a small sample of each cell suspension was diluted 1:1 in trypan blue and counted under a light microscope. The effects of the treatment were quantified as the percentage of cell survival using DMSO as the control. Apoptosis analysis. Cells (3x10 6 ) in a 60-mm tissue culture dish with 100 µM of capsaicin and/or 50 µM of resveratrol were incubated for 48 h. Cells were harvested by trypsinization, centrifugation and measured by a Becton-Dickinson FACScan (excitation at 488 nm) equipped with CellQuest software following Annexin V-FITC and propidium iodide staining, which was performed by modification of a previously described (19) protocol. Apoptotic cells were labeled with Annexin V (early apoptosis) or with Annexin V and propidium iodide (late apoptosis); necrotic cells were stained with propidium iodide and living cells were negative for the two stains. Cells treated with DMSO and 50 µM etoposide were used as a negative and positive control, respectively.
Determination
DNA fragmentation. For analysis of DNA fragmentation by agarose gel electrophoresis, total DNA was isolated from cells treated with 100 µM of capsaicin and/or 50 µM of resveratrol for 48 h using a GenElute™ mammalian genomic DNA miniprep kit. The isolated DNA was suspended in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 9.0) and quantified by absorbance at 260 nm. Fragmented DNA was loaded onto 1.8% agarose gel containing 1X TBE buffer and separated by electrophoresis for 2 h at 50 V, and images were captured following staining with 0.5 ng/ml ethidium bromide.
Whole cell extract and mitochondria-free cytosolic fraction preparation. Cells were harvested following treatment for 48 h and were lysed in 450 µl of ice-cold RIPA lysis buffer [1X TBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 0.004% sodium azide, 1 mM phenylmethylsufonyl fluoride (PMSF), sodium orthovanadate supplemented with 20 µg/ ml protease inhibitor cocktail; Santa Cruz Biotechnology] for 30-60 min on ice, centrifuged at 10,000 x g for 10 min at 4˚C, and the protein concentration in the resulting supernatant was measured by the Bradford method (Bio-Rad, Hercules, CA, USA) prior to Western blot analysis.
Cytosolic fractions from control and treated cells were prepared using a kit from BioVision. Briefly, cells (3x10 6 ) were treated with 100 µM of capsaicin and/or 50 µM of resveratrol for 48 h. The cells were collected, pelleted by centrifugation and washed with ice-cold phosphate-buffered saline (PBS). The cells were suspended in cytosol extraction buffer supplied by the manufacturer and incubated on ice for 10 min. The cells were then homogenized using an ice-cold dounce tissue grinder, and the homogenate was centrifuged at 10,000 x g for 30 min to separate cytosol and mitochondria. The supernatant, including the cytosolic fraction, was collected and frozen at -80˚C for cytochrome c analysis.
Western blot analysis.
Approximately 60 µg of protein from the whole-cell lysate or the cytosolic fractions was denatured, separated by 15% (or 7.5% for NOS isoforms) SDS-PAGE gel electrophoresis and blotted onto a polyvinylidene difluoride (PVDF) membrane (Bio-Rad), which was then blocked with 5-7% (w/v) non-fat dry milk in Tris-buffered saline/0.1% Tween-20 (TBS/T, pH 7.6) for 1-3 h at room temperature. The membranes were incubated at 4˚C overnight with either anti-NOS1 (diluted 1:500), anti-NOS2 (1:500), anti-NOS-3 (1:1000), anti-p53 (1:1000), anti-Mdm2 (1:1000), anti-Bax (1:1000), anti-bcl-2 (1:1000), anti-DR4 (1:1000), anti-Fas(CD95) (1:2000), anti-caspase 8 (1:1000), anti-caspase 9 (1:1000), anti-cytochrome c (1:2000), anti-caspase 3 (1:1000), or anti-actin (1:8000). After being washed twice for 10 min with TBS/T, blots were incubated with the corresponding peroxidase-conjugated secondary goat anti-rabbit or mouse IgG (diluted 1:8000) for 1 h at room temperature, followed by washing 2 times for 5 min and 4 times for 10 min, and detection of enhanced chemiluminescence by exposure to Hyperfilm ECL.
Caspase 3 activity assay. The caspase 3 activity of treated cells was determined using an ApoAlert Caspase-3 Colorimetric Assay kit. Cells (2x10 6 ) were counted and centrifuged at 400 x g for 5 min, resuspended in 50 ml of chilled cell lysis buffer, and then incubated on ice for 10 min. Cell lysates were centrifuged at 16,000 x g for 10 min at 4˚C to precipitate cellular debris. A total amount of 50 µl of 2X reaction buffer/DTT mix and 50 µM of caspase 3 substrate DEVD-pNA were added to each transferred supernatant. The samples were incubated at 37˚C for 1-3 h in a water bath, and read at 405 nm using a µQuant plate reader from Biotek Instruments Inc. (Winooski, VT, USA).
Statistical analysis. The two-tailed Student's t-test was used to
analyze the statistical analysis between the capsaicin-and/or resveratrol-treated and control groups.
Results
Effect of capsaicin and/or resveratrol on cell viability. Cells were treated with 0, 10, 25, 50, 100 and 200 µM of capsaicin or resveratrol for 24 h. Capsaicin and resveratrol decreased the percentage of viable cells dose-dependently (Fig. 1A) . Following exposure to 100 µM capsaicin and 50 µM resveratrol for 24 h, viability was 43 and 40%, respectively (Fig. 1A) .
We next assessed the time course of viability using these doses of the two compounds, alone or in combination, and the percentage of viable cells was decreased in a time-dependent manner; the highest cytotoxic effect was observed when used in combination (100 µM capsaicin + 50 µM resveratrol) (Fig. 1B) .
Expression of NOS isoenzyme protein and total NO
• production. Western blot analysis showed the expression of 3 NOS isoforms in A375 cells treated with capsaicin and/or resveratrol ( Fig. 2A) . Resveratrol alone or in combination with capsaicin produced major differences in nNOS and iNOS.
Rates of total NO • production were calculated from concentrations of NO 3 -plus NO 2 -in culture media following treatment for 6-48 h. As summarized in Fig. 2B , time-dependent increases in rates of total NO
• production were observed in cells in response to all treatments. Cells treated with either capsaicin or resveratrol alone for 48 h showed 2-to 40-fold increases in the NO
• production rate, as compared with controls, and the increases were further enhanced by combination treatment.
Effect of NMA on capsaicin and/or resveratrol induced cell growth inhibition. As shown in Fig. 2A and B, capsaicin and/ or resveratrol was a potent NO
• inducer. In order to investigate whether NO
• production interfered with cell growth, we incubated melanoma cells with 1 and 2 mM of NMA, an NOS inhibitor. When cells were incubated with capsaicin and/or resveratrol and increasing concentrations of NMA, (Fig. 2C) . Our results indicate that the enhanced NO
• production is a prerequi site for cell growth inhibition induced by capsaicin and/or resveratrol. Fig. 3A shows that capsaicin and/or resveratrol induced apoptosis in A375 cells. Approximately 20% of cells were apoptotic following capsaicin treatment and 45% following resveratrol treatment in A375 cells (2.1-and 4.7-fold over control level); combined treatment was more effective compared to either capsaicin or resveratrol alone (Fig. 3A) .
Apoptosis of A375 cells identified by flow cytometric analysis.
Internucleosomal DNA fragmentation. One of the biochemical features of apoptosis is the fragmentation of genomic DNA; therefore, we isolated the genomic DNA after treating the cells for 48 h with capsaicin and/or resveratrol. The two compounds induced a DNA ladder formation; combined treatment was more effective than either capsaicin or resveratrol alone. Laddering confirmed death by apoptosis of the melanoma cells treated with these compounds (Fig. 3B) .
Expression of intrinsic apoptotic pathway-regulating proteins p53, Mdm2, Bax and Bcl-2.
As a next step, we investigated the mechanisms underlying capsaicin-and resveratrol-induced cell death with a focus upon apoptosis-regulating proteins. For this purpose, we first examined the expression of p53, Mdm2, Bax and Bcl-2 proteins. Treatment of the cells with capsaicin and/or resveratrol for 48 h led to a substantial elevation in cellular p53 levels accompanied by decrease in Mdm2 levels in A375 cells (Fig. 4A) . The highest p53 and lowest Mdm2 levels were observed in the combination treatment, showing that capsaicin plus resveratrol accelerated the release of p53 by Mdm2 and its accumulation in the nuclei. The Bax gene, a proapoptotic member of the Bcl-2 family, is a significant target for p53. Our results from the Western blot analysis showed a slight elevation in Bax protein level and a pronounced down-regulation in Bcl-2 upon capsaicin and/or resveratrol treatment (Fig. 4A) .
Expression of extrinsic apoptotic pathway-regulating proteins DR4, Fas and caspase 8.
Next, we considered whether the extrinsic pathway was involved in the death of treated A375 melanoma cells. We analyzed the activation of DR4, Fas and caspase 8 in these treated and untreated cell lines. Western blot analysis reported in Fig. 4B shows an increase in DR4 and Fas (CD95), though a decrease in procaspase 8 protein level after capsaicin and/or resveratrol. When cells were treated with combined treatment, the level of their activation was maximum or minimum similar to other apoptosis regulatory proteins (Fig. 4B ). An increased protein degradation of the cleaved form of caspase 8 in the capsaicin and/or resveratrol treated melanoma could explain the lack of this active form (43 and 18 kDa) in the Western blot analysis. These findings suggested that the intrinsic and extrinsic apoptotic pathways are involved in the death of the treated melanoma cells. 
Caspase-dependent cascade (caspase 9, cytochrome c and caspase 3).
It is well known that a variety of stress stimuli lead to activation of caspases; therefore, we examined by Western blotting whether the apoptotic death induced by capsaicin and/ or resveratrol was caspase-dependent. We found a decrease in the precursor form of caspase 9 and cytochrome c release in the capsaicin-and/or resveratrol-treated cells (Fig. 4C) . Accordingly, data from the Western blot analysis showed that degradation of procaspase 3 is accompanied by a significant increase in caspase 3 activity in the colorimetric assay based on the cleavage of the synthetic peptide Ac-DEVD-pNA (Fig. 4D) . To investigate whether caspase 3 activity is critical for the capsaicin-and resveratrol-induced growth inhibition, we pretreated these cells with caspase 3 inhibitor, Ac-DEVD-CHO. As shown in Fig. 4E , Ac-DEVD-CHO attenuated capsaicin and/or resveratrol-induced growth inhibition, indicating that caspase 3 activity may be involved in the induction of growth inhibition by these agents.
Discussion
The aim of this study was to dissect the biochemical and molecular events associated with programmed cell death in melanoma following treatment with capsaicin and resveratrol. Although the anticancer function of capsaicin and resveratrol remains controversial, our results have clearly demonstrated that capsaicin and resveratrol inhibit cell growth (Fig. 1 ) and promote apoptosis (Fig. 3) in the cell line A375. Data presented here of increased NO
• production with capsaicin and resveratrol treatment and the activation of NOS levels (Fig. 2) , suggest that NO
• regulation accounts for the mechanism of capsaicin and resveratrol's action in this cell line.
The specific role of NO • in tumor biology and cancer remains elusive; the generation of NO
• by tumor cells may inhibit activation and proliferation or increase apoptosis of surrounding lymphocytes that could account for the immune suppression observed that accompanies tumor growth, whereas, high intratumoral output of NO • could inhibit the activation of caspases and, therefore, antagonize the pro-apoptotic signal (20, 21) . However, the opposite effect also has been observed in numerous other systems whereby the generation of high output of NO • , either iNOS inducted or by the use of NO
• donors, inhibits tumor growth and metastasis (21, 22) . The final outcome of NO
• -mediated effects is variable, depending on a number of factors including cell type, NO
• concentration, exposure duration, sources of NO
• and intracellular redox status. Significantly, in this present study, we demonstrated that capsaicin and resveratrol cause an up-regulation of NOS activity and, in turn, produce an increase in NO
• , leading to cell death in A375 cells (Figs. 1 and 2 ). In addition, we showed that a combined treatment induced the strongest response compared with either capsaicin or resveratrol alone ( Fig. 2A and B) . Moreover, using NMA, a NOS inhibitor, cell growth returned to normal levels (Fig. 2C) , confirming that capsaicin-and resveratrol-induced NO
• production contributes to the overall fate of A375 cells. DNA fragmentation suggested that capsaicin-and/or resveratrol-induced cell death involved a mechanism of apoptosis, and this hypothesis was confirmed by flow cytometric analysis (Fig. 3) . In fact, approximately half of the A375 cells became permeable to PI and Annexin V after 48 h with the combination treatment (Fig. 3A) . A dual role of capsaicin and resveratrol in modulating NO
• production has been reported. A number of investigators have found that these compounds suppress NO
• production, whereas others have observed enhancement of NO
• production. Capsaicin (23-25) and resveratrol (26) inhibited IFN-γ and LPS-mediated NO • production and iNOS protein expression in RAW264.7 macrophages, and resveratrol reduced NO
• production in leukemic cells (27) . The data that we present here indicate a direct relationship between increased NO • production and programmed tumor cell death (Figs. 1-3 ) by treatment with resveratrol and capsaicin. These data are supported by previous reports that capsaicin promotes iNOS expression and NO
• production and leads to inhibition of proliferation in PC-12 (14) and C6 glioma (15) cells. Furthermore, the literature indicates that resveratrol increases NO
• production and induction of apoptosis in MCF-7 human breast cancer (16), HepG2 hepatocellular carcinoma (17) and gastric adenocarcinoma (28) cells.
Mammalian cells have two major apoptotic pathways, the intrinsic and extrinsic, which converge on the activation of the initiator and of the effector caspases (13, 21, 29) . The intrinsic pathway is dependent on the release of mitochondrial cytochrome c and other pro-apoptotic molecules into the cytoplasm. The association of cytochrome c with an adapter molecule, Apaf1, which activates caspase 9 in the cytoplasm, which, in turn, activates downstream caspases (13, 21, 29) has been noted. Expression of wild-type p53 released by Mdm2 increases the sensitivity of cells to apoptosis and regulates Bcl-2 family proteins which modulate the mitochondrial pathway of apoptosis (13, 21, 29) . In the extrinsic pathway, the binding of specific death ligands to their respective cell surface receptors, such as Fas (CD95), tumor necrosis factor (TNF) receptor (TNFR), and the TNF-related apoptosis-inducing ligand (TRAIL) receptors DR4 and DR5, activate downstream pathways through the recruitment of an initiator (caspase 8), which, in turn, cleaves further effector caspases (13, 21) . Thus, in order to understand the p53-related mechanisms used by capsaicin and resveratrol to activate the apoptotic pathway, we first analyzed the expression of p53, Mdm2 and the Bcl-2 family utilizing A375 cells (Fig. 4A ). Capsaicin and/or resveratrol exposure stimulated p53 as well as Bax expression, while the p53 regulator gene Mdm2 was distinctly inhibited in A375 cells. Reduction of the anti-apoptotic p53-downstream target Bcl-2 expression was consequently detectable in A375 cells, suggesting that reduced levels of anti-apoptotic Bcl-2 protein, which are p53-and Bax-independent, play a role in cytochrome c release and apoptosis induced by capsaicin and resveratrol (Fig. 4A) . Our results agree with previous findings that capsaicin and resveratrol modulate the processes of apoptosis in tumor cells through caspase activation accelerated by the decreased level of Bcl-2 (15, 30, 31) . We also found the activation of caspase 9 together with caspase 3, indicating that these compounds induce apoptosis via the mitochondrial pathway. Up-regulation of DR4 and Fas (CD95) and activation of caspase 8 (Fig. 4B ) suggest that these compounds activate both the mitochondrial and death receptor pathways and work together to induce apoptosis ( Fig. 4A and B) . Although the mitochondrial and death receptor pathways are distinct, there is considerable crosstalk between them (13, 21) . For example, activated caspase 8 in response to TNF-α can cleave Bid, a Bcl-2 family member, thereby converting Bid to a pro-apoptotic molecule that could promote cytochrome c release (21) . In this study, we found that capsaicin and/or resveratrol induce the release of cytochrome c into the cytosol, confirming the existence of the two apoptotic pathways (Fig. 4C) .
Caspases play an essential role in the apoptotic signal cascade. Caspases 8 and 9 are initiator caspases capable of transducing apoptotic signals by directly activating the downstream executioner caspase 3 (13, 21, 29) . A number of studies have shown that NO
• induces caspase-dependent apoptosis via both mitochondrial and death receptor pathways (13) , and this prompted us to investigate whether NO
• is a target molecule in capsaicin-and resveratrol-induced apoptosis. We report, here, that these compounds promoted the activity of caspase 3 by colorimetric assay (Fig. 4D) . We also showed that the addition of caspase 3 inhibitor, Ac-DEVD-CHO, inhibited caspase 3 activity and led to growth in these cells (Fig. 4E ). These results demonstrate that capsaicin-and resveratrol-induced apoptosis might involve NO
• -and a caspase 3-mediated mechanism. Capsaicin and resveratrol have been reported to induce apoptosis through the multiple and contradictory death signaling events; caspase activation dependent (16, 32) and independent (33) of cytochrome c release, p53 and/or Bax-dependent (34) and -independent (35) cell death and death receptor dependent death signaling (36) . For instance, the decrease in Bcl-2 levels is associated with cytochrome c release from the mitochondria and caspase-mediated apoptosis in numerous cases, while, in MCF-7 cells, even at high concentrations, resveratrol was unable to release cytochrome c to the cytosolic compartment in such a way (16) . Therefore, whether capsaicin and resveratrol could induce cell death depends on the concentration exposed, the duration of exposure, the availability and efficiency of antioxidant capacity, as well as on the cell type.
Compared to capsaicin or resveratrol alone, a combination of the compounds was more effective in several significant antitumoric bioactivities, including NO
• production, DNA fragmentation and induction of apoptosis. Although this is not a synergistic effect, further studies are required to elucidate the mechanism of interaction between capsaicin and resveratrol for increased apoptotic potential. Our results suggest that tumor-associated NO
• is likely to be involved in the control of cancer. Thus, investigation of NO
• -centered anticancer strategies is crucial; the source, output, chemistry and activity of NO
• in the tumor environment and the target cell type remain areas for further investigation.
In conclusion, we propose a mechanism for the capsaicin-and resveratrol-induced apoptotic pathway in human melanoma; the mitochondrial and death receptor pathways work together to induce apoptosis. These findings suggest that recognition of NO
• as a target for apoptosis may provide a potential therapeutic strategy.
